Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
3.150
+0.190 (6.42%)
At close: Mar 9, 2026, 4:00 PM EDT
3.160
+0.010 (0.32%)
After-hours: Mar 9, 2026, 4:12 PM EDT
Agenus Employees
Agenus had 316 employees as of December 31, 2024. The number of employees decreased by 73 or -18.77% compared to the previous year.
Employees
316
Change (1Y)
-73
Growth (1Y)
-18.77%
Revenue / Employee
$338,066
Profits / Employee
-$111,968
Market Cap
107.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 134 |
| Fortress Biotech | 101 |
| Korro Bio | 87 |
| Precision BioSciences | 67 |
| Biomea Fusion | 42 |
| Vivani Medical | 37 |
| Equillium | 35 |
| Cassava Sciences | 30 |
AGEN News
- 4 days ago - Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update - Business Wire
- 18 days ago - Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL - Business Wire
- 4 weeks ago - Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors - Business Wire
- 5 weeks ago - Agenus Inc. (AGEN) Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives Transcript - Seeking Alpha
- 6 weeks ago - Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab - Business Wire
- 6 weeks ago - Agenus to Host First 2026 Stakeholder Webcast - Business Wire
- 7 weeks ago - Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S. - PRNewsWire
- 7 weeks ago - Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness - Business Wire